The Safety and Effects of Gefitinib in Triple-negative,EGFR Positive Metastatic Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: gefitinib
Sponsor: Jiangmen Central Hospital